nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—SLC36A2—gonad—testicular cancer	0.189	0.417	CbGeAlD
Cycloserine—SLC36A2—testis—testicular cancer	0.136	0.3	CbGeAlD
Cycloserine—DDC—embryo—testicular cancer	0.0697	0.153	CbGeAlD
Cycloserine—Paresis—Chlorambucil—testicular cancer	0.0525	0.0962	CcSEcCtD
Cycloserine—Neurological symptom—Cisplatin—testicular cancer	0.0362	0.0663	CcSEcCtD
Cycloserine—DDC—testis—testicular cancer	0.0341	0.0751	CbGeAlD
Cycloserine—DDC—lymph node—testicular cancer	0.0247	0.0544	CbGeAlD
Cycloserine—Aggression—Bleomycin—testicular cancer	0.0169	0.0309	CcSEcCtD
Cycloserine—Paresis—Methotrexate—testicular cancer	0.0164	0.0301	CcSEcCtD
Cycloserine—Drug hypersensitivity—Epirubicin—testicular cancer	0.0139	0.0255	CcSEcCtD
Cycloserine—Dysarthria—Ifosfamide—testicular cancer	0.0134	0.0245	CcSEcCtD
Cycloserine—Drug hypersensitivity—Doxorubicin—testicular cancer	0.0129	0.0236	CcSEcCtD
Cycloserine—Disorientation—Bleomycin—testicular cancer	0.012	0.022	CcSEcCtD
Cycloserine—Coma—Ifosfamide—testicular cancer	0.0116	0.0212	CcSEcCtD
Cycloserine—Dysarthria—Cisplatin—testicular cancer	0.0115	0.0212	CcSEcCtD
Cycloserine—Disorientation—Ifosfamide—testicular cancer	0.0103	0.0188	CcSEcCtD
Cycloserine—Osteoarthritis—Ifosfamide—testicular cancer	0.00919	0.0169	CcSEcCtD
Cycloserine—Psychotic disorder—Ifosfamide—testicular cancer	0.00898	0.0165	CcSEcCtD
Cycloserine—Cardiac failure congestive—Cisplatin—testicular cancer	0.00874	0.016	CcSEcCtD
Cycloserine—Cardiac failure congestive—Etoposide—testicular cancer	0.00801	0.0147	CcSEcCtD
Cycloserine—Tremor—Chlorambucil—testicular cancer	0.00784	0.0144	CcSEcCtD
Cycloserine—Convulsion—Chlorambucil—testicular cancer	0.00725	0.0133	CcSEcCtD
Cycloserine—Vertigo—Vinblastine—testicular cancer	0.00689	0.0126	CcSEcCtD
Cycloserine—Confusional state—Chlorambucil—testicular cancer	0.00689	0.0126	CcSEcCtD
Cycloserine—Convulsion—Vinblastine—testicular cancer	0.00665	0.0122	CcSEcCtD
Cycloserine—Dysarthria—Methotrexate—testicular cancer	0.00634	0.0116	CcSEcCtD
Cycloserine—Dysarthria—Epirubicin—testicular cancer	0.00593	0.0109	CcSEcCtD
Cycloserine—Feeling abnormal—Chlorambucil—testicular cancer	0.00563	0.0103	CcSEcCtD
Cycloserine—Paraesthesia—Vinblastine—testicular cancer	0.00562	0.0103	CcSEcCtD
Cycloserine—Dysarthria—Doxorubicin—testicular cancer	0.00549	0.0101	CcSEcCtD
Cycloserine—Coma—Methotrexate—testicular cancer	0.00548	0.01	CcSEcCtD
Cycloserine—Confusional state—Bleomycin—testicular cancer	0.00533	0.00977	CcSEcCtD
Cycloserine—Feeling abnormal—Vinblastine—testicular cancer	0.00516	0.00945	CcSEcCtD
Cycloserine—Coma—Epirubicin—testicular cancer	0.00512	0.00939	CcSEcCtD
Cycloserine—Hypersensitivity—Chlorambucil—testicular cancer	0.00503	0.00922	CcSEcCtD
Cycloserine—Vertigo—Ifosfamide—testicular cancer	0.00497	0.00912	CcSEcCtD
Cycloserine—Convulsion—Ifosfamide—testicular cancer	0.0048	0.00879	CcSEcCtD
Cycloserine—Paraesthesia—Bleomycin—testicular cancer	0.00475	0.0087	CcSEcCtD
Cycloserine—Coma—Doxorubicin—testicular cancer	0.00474	0.00869	CcSEcCtD
Cycloserine—Hypersensitivity—Vinblastine—testicular cancer	0.00461	0.00845	CcSEcCtD
Cycloserine—Confusional state—Ifosfamide—testicular cancer	0.00456	0.00835	CcSEcCtD
Cycloserine—Cardiac failure congestive—Epirubicin—testicular cancer	0.00449	0.00823	CcSEcCtD
Cycloserine—Tremor—Cisplatin—testicular cancer	0.00447	0.0082	CcSEcCtD
Cycloserine—Feeling abnormal—Bleomycin—testicular cancer	0.00436	0.00799	CcSEcCtD
Cycloserine—Osteoarthritis—Methotrexate—testicular cancer	0.00435	0.00797	CcSEcCtD
Cycloserine—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00415	0.00761	CcSEcCtD
Cycloserine—Convulsion—Cisplatin—testicular cancer	0.00414	0.00758	CcSEcCtD
Cycloserine—Osteoarthritis—Epirubicin—testicular cancer	0.00407	0.00746	CcSEcCtD
Cycloserine—Feeling abnormal—Dactinomycin—testicular cancer	0.00406	0.00745	CcSEcCtD
Cycloserine—Paraesthesia—Ifosfamide—testicular cancer	0.00406	0.00744	CcSEcCtD
Cycloserine—Somnolence—Ifosfamide—testicular cancer	0.00402	0.00736	CcSEcCtD
Cycloserine—Vertigo—Etoposide—testicular cancer	0.00393	0.0072	CcSEcCtD
Cycloserine—Headache—Vinblastine—testicular cancer	0.00392	0.00719	CcSEcCtD
Cycloserine—Hypersensitivity—Bleomycin—testicular cancer	0.0039	0.00714	CcSEcCtD
Cycloserine—Convulsion—Etoposide—testicular cancer	0.00379	0.00694	CcSEcCtD
Cycloserine—Osteoarthritis—Doxorubicin—testicular cancer	0.00377	0.0069	CcSEcCtD
Cycloserine—Feeling abnormal—Ifosfamide—testicular cancer	0.00372	0.00682	CcSEcCtD
Cycloserine—Hypersensitivity—Dactinomycin—testicular cancer	0.00363	0.00666	CcSEcCtD
Cycloserine—Confusional state—Etoposide—testicular cancer	0.0036	0.0066	CcSEcCtD
Cycloserine—Paraesthesia—Cisplatin—testicular cancer	0.0035	0.00641	CcSEcCtD
Cycloserine—Drowsiness—Methotrexate—testicular cancer	0.00335	0.00614	CcSEcCtD
Cycloserine—Rash—Bleomycin—testicular cancer	0.00333	0.00611	CcSEcCtD
Cycloserine—Dermatitis—Bleomycin—testicular cancer	0.00333	0.0061	CcSEcCtD
Cycloserine—Hypersensitivity—Ifosfamide—testicular cancer	0.00333	0.0061	CcSEcCtD
Cycloserine—Feeling abnormal—Cisplatin—testicular cancer	0.00321	0.00588	CcSEcCtD
Cycloserine—Paraesthesia—Etoposide—testicular cancer	0.0032	0.00587	CcSEcCtD
Cycloserine—Somnolence—Etoposide—testicular cancer	0.00317	0.00581	CcSEcCtD
Cycloserine—Drowsiness—Epirubicin—testicular cancer	0.00314	0.00575	CcSEcCtD
Cycloserine—Rash—Dactinomycin—testicular cancer	0.00311	0.0057	CcSEcCtD
Cycloserine—Feeling abnormal—Etoposide—testicular cancer	0.00294	0.00539	CcSEcCtD
Cycloserine—Drowsiness—Doxorubicin—testicular cancer	0.0029	0.00532	CcSEcCtD
Cycloserine—Hypersensitivity—Cisplatin—testicular cancer	0.00287	0.00526	CcSEcCtD
Cycloserine—Rash—Ifosfamide—testicular cancer	0.00285	0.00522	CcSEcCtD
Cycloserine—Dermatitis—Ifosfamide—testicular cancer	0.00285	0.00522	CcSEcCtD
Cycloserine—Hypersensitivity—Etoposide—testicular cancer	0.00263	0.00482	CcSEcCtD
Cycloserine—Rash—Cisplatin—testicular cancer	0.00246	0.0045	CcSEcCtD
Cycloserine—Dermatitis—Cisplatin—testicular cancer	0.00245	0.0045	CcSEcCtD
Cycloserine—Vertigo—Methotrexate—testicular cancer	0.00235	0.00431	CcSEcCtD
Cycloserine—Convulsion—Methotrexate—testicular cancer	0.00227	0.00416	CcSEcCtD
Cycloserine—Rash—Etoposide—testicular cancer	0.00225	0.00412	CcSEcCtD
Cycloserine—Dermatitis—Etoposide—testicular cancer	0.00225	0.00412	CcSEcCtD
Cycloserine—Headache—Etoposide—testicular cancer	0.00224	0.0041	CcSEcCtD
Cycloserine—Vertigo—Epirubicin—testicular cancer	0.0022	0.00404	CcSEcCtD
Cycloserine—Confusional state—Methotrexate—testicular cancer	0.00216	0.00395	CcSEcCtD
Cycloserine—Convulsion—Epirubicin—testicular cancer	0.00212	0.00389	CcSEcCtD
Cycloserine—Vertigo—Doxorubicin—testicular cancer	0.00204	0.00373	CcSEcCtD
Cycloserine—Confusional state—Epirubicin—testicular cancer	0.00202	0.0037	CcSEcCtD
Cycloserine—Convulsion—Doxorubicin—testicular cancer	0.00197	0.0036	CcSEcCtD
Cycloserine—Paraesthesia—Methotrexate—testicular cancer	0.00192	0.00352	CcSEcCtD
Cycloserine—Somnolence—Methotrexate—testicular cancer	0.0019	0.00348	CcSEcCtD
Cycloserine—Confusional state—Doxorubicin—testicular cancer	0.00187	0.00342	CcSEcCtD
Cycloserine—Paraesthesia—Epirubicin—testicular cancer	0.0018	0.00329	CcSEcCtD
Cycloserine—Somnolence—Epirubicin—testicular cancer	0.00178	0.00326	CcSEcCtD
Cycloserine—Feeling abnormal—Methotrexate—testicular cancer	0.00176	0.00323	CcSEcCtD
Cycloserine—Paraesthesia—Doxorubicin—testicular cancer	0.00166	0.00305	CcSEcCtD
Cycloserine—Feeling abnormal—Epirubicin—testicular cancer	0.00165	0.00302	CcSEcCtD
Cycloserine—Somnolence—Doxorubicin—testicular cancer	0.00165	0.00302	CcSEcCtD
Cycloserine—Hypersensitivity—Methotrexate—testicular cancer	0.00158	0.00289	CcSEcCtD
Cycloserine—Feeling abnormal—Doxorubicin—testicular cancer	0.00153	0.0028	CcSEcCtD
Cycloserine—Hypersensitivity—Epirubicin—testicular cancer	0.00147	0.0027	CcSEcCtD
Cycloserine—Hypersensitivity—Doxorubicin—testicular cancer	0.00136	0.0025	CcSEcCtD
Cycloserine—Rash—Methotrexate—testicular cancer	0.00135	0.00247	CcSEcCtD
Cycloserine—Dermatitis—Methotrexate—testicular cancer	0.00135	0.00247	CcSEcCtD
Cycloserine—Headache—Methotrexate—testicular cancer	0.00134	0.00245	CcSEcCtD
Cycloserine—Rash—Epirubicin—testicular cancer	0.00126	0.00231	CcSEcCtD
Cycloserine—Dermatitis—Epirubicin—testicular cancer	0.00126	0.00231	CcSEcCtD
Cycloserine—Headache—Epirubicin—testicular cancer	0.00125	0.0023	CcSEcCtD
Cycloserine—Rash—Doxorubicin—testicular cancer	0.00117	0.00214	CcSEcCtD
Cycloserine—Dermatitis—Doxorubicin—testicular cancer	0.00117	0.00214	CcSEcCtD
Cycloserine—Headache—Doxorubicin—testicular cancer	0.00116	0.00213	CcSEcCtD
